162 The OI Show: Down with OCT With Dr. Nate Lighthizer

Dr. Nate Lighthizer, Dean of the Oklahoma College of Optometry, talks about advanced OCT technology. From the ganglion cell complex to nerve fiber layer analysis, Dr. Lighthizer shares invaluable insights on how OCT is revolutionizing glaucoma diagnosis and management. 

💡 Learn how to leverage OCT and OCTA for better patient care, the importance of progression analysis, and why ganglion cells may be the first indicator of glaucoma. 

About Dr. Lighthizer

Born and raised in Bismarck, North Dakota, Dr. Nate Lighthizer, O.D., F.A.A.O., is a graduate of Pacific University College of Optometry.  Upon graduation, he completed a residency in Family Practice Optometry with an emphasis in Ocular Disease and Laser and Surgical Optometry through Northeastern State University Oklahoma College of Optometry (NSUOCO).  Dr. Lighthizer has since joined the faculty at the Oklahoma College of Optometry and has served as the Chief of Specialty Care Clinics and the Chief of Electrodiagnostics Clinic.   In 2014, he founded and now heads the Dry Eye Clinic at the College of Optometry.  Also in 2014, he was named the Director of Continuing Education as well as the Assistant Dean for Clinical Care Services at the Oklahoma College of Optometry.  Starting in 2020, he was named the Associate Dean of the NSU Oklahoma College of Optometry.  In July 2024, he was named the Dean of the Oklahoma College of Optometry.  He is a founding member, and currently serves as Immediate Past President, of the Intrepid Eye Society which is a group of emerging thought leaders in optometry.  He was named a member of PCON 250 – A list of the top 250 optometrists in the country who practice progressively, provide innovative patient care, conduct optometric research or excel in academia and share what they have learned with other optometrists to advance the profession.  Dr. Lighthizer lectures nationally and internationally on numerous topics, most notably advanced ophthalmic procedures, electrodiagnostics, and ocular disease.